Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons

BACKGROUND: Ovarian cancer is one of the deadliest gynecological diseases and the annual mortality of ovarian cancer continues to rise. The prognosis of ovarian cancer is poor because it is prone to early metastasis during progression. Therefore, early diagnosis of ovarian cancer is very important....

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Jinyong, Liu, Jing, Hua, Mengge, Cai, Runjin, Li, Muyang, Wang, Jing, Wang, Jiancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504260/
https://www.ncbi.nlm.nih.gov/pubmed/31045839
http://dx.doi.org/10.1097/MD.0000000000015508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504260/
https://www.ncbi.nlm.nih.gov/pubmed/31045839
http://dx.doi.org/10.1097/MD.0000000000015508

Ejemplares similares